Want to see HK:2509 full AI Analyst Report?

Qyuns Therapeutics Co., Ltd. Class H (2509) Financial Statements

1 Followers

Qyuns Therapeutics Co., Ltd. Class H Financial Overview

Qyuns Therapeutics Co., Ltd. Class H's market cap is currently HK$3.86B. The company's EPS TTM is HK$2.42; its P/E ratio is 6.03; Qyuns Therapeutics Co., Ltd. Class H is scheduled to report earnings on August 19, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 786.08M	¥ 158.79M	¥ 14.75M	¥ 9.66M	¥ 21.35M
Gross Profit	¥ 664.66M	¥ 92.19M	¥ -32.96M	¥ 9.66M	¥ -9.56M
Operating Income	¥ 319.74M	¥ -326.37M	¥ -504.51M	¥ -293.69M	¥ -168.62M
EBITDA	¥ 351.00M	¥ -311.82M	¥ -484.12M	¥ -295.51M	¥ -155.65M
Net Income	¥ 306.31M	¥ -335.57M	¥ -507.75M	¥ -298.19M	¥ -411.04M
Balance Sheet
Cash & Short-Term Investments	¥ 1.04B	¥ 556.55M	¥ 377.25M	¥ 689.57M	¥ 620.44M
Total Assets	¥ 1.60B	¥ 983.88M	¥ 795.58M	¥ 1.16B	¥ 1.07B
Total Debt	¥ 580.26M	¥ 527.60M	¥ 346.06M	¥ 295.25M	¥ 290.26M
Net Debt	¥ -381.90M	¥ 166.91M	¥ 129.76M	¥ 82.16M	¥ 72.21M
Total Liabilities	¥ 921.62M	¥ 762.83M	¥ 494.63M	¥ 373.69M	¥ 363.33M
Stockholders' Equity	¥ 694.33M	¥ 228.98M	¥ 294.76M	¥ 641.72M	¥ 670.35M
Cash Flow
Free Cash Flow	¥ 392.23M	¥ -187.85M	¥ -308.63M	¥ -301.70M	¥ -228.64M
Operating Cash Flow	¥ 399.85M	¥ -186.09M	¥ -300.68M	¥ -275.23M	¥ -157.60M
Investing Cash Flow	¥ 118.69M	¥ -25.23M	¥ 243.11M	¥ -5.70M	¥ -247.42M
Financing Cash Flow	¥ 93.73M	¥ 351.81M	¥ 61.21M	¥ 211.49M	¥ 281.48M

Currency in CNY

Qyuns Therapeutics Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Qyuns Therapeutics Co., Ltd. Class H Debt to Assets

Balance Sheet >

Qyuns Therapeutics Co., Ltd. Class H Cash Flow

Cash Flow >

Qyuns Therapeutics Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >